---
figid: PMC5144105__gr2
figlink: /pmc/articles/PMC5144105/figure/f0010/
number: Fig. 2
caption: 'Signal transduction pathways in cranial development. The figure schematically
  illustrates the central signal transduction cascades implicated in cranial suture
  development. Possible impairment of these pathways can lead to premature cranial
  fusion thus craniosynostosis. FGF signaling: FGFs (FGF4, FGF3) bind to FGF receptor
  Tyr kinases; FGFRs are phosphorylated hence activated and further activate intracellular
  substrates, which initiate downstream signaling pathways such as the RAS–MAPK pathway.
  The phosphorylated ERK1/2 translocates to the nucleus where it interacts with the
  transcription factor ERF, which is then exported from the nucleus. Within the nucleus
  ERF can bind to RUNX2 and repress RUNX2 expression. TWIST also represses RUNX2 by
  forming a heterodimer with TCF12. Mutations in FGFRs are associated with craniosynostosis
  syndromes, as over-expression of FGFRs triggers the constant expression of ERK1/2,
  thus RUNX2 expression is not abrogated and osteogenesis occurs. TGF-β signaling:
  TGF-β signaling is correlated with downstream ERK1/2. BMP signaling: BMPs bind to
  type I/II transmembrane receptors. Activated receptors initiate signaling by phosphorylating
  downstream targets Smad1, Smad5, Smad8 proteins, which interact with Smad4 which
  translocates into the nucleus. BMP over-expression leads to the expression of RUNX2,
  thus to cranial fusion. BMP signaling is regulated by the antagonist Noggin. Wnt
  signaling: The Wnts signal through the canonical β-catenin pathway. Wnts bind to
  FZD receptors and an accumulation of β-catenin is triggered. β-catenin translocates
  to the nucleus and binds to TCF/LEF transcription factors. Subsequent transcription
  of osteogenic markers follows. BMP, bone morphogenetic protein; BMPR, bone morphogenetic
  protein receptor; CK1, casein kinase 1; DVL, the scaffolding protein Disheveled;
  ERF, ETS domain-containing transcription factor; ERK1/2, extracellular signal-regulated
  kinase 1/2; FGF3 and FGF4, fibroblast growth factors 3,4; FGFR1/2/3, fibroblast
  growth factor receptors 1/2/3; FRAT1 proto-oncogene; FZD, Frizzled receptor; GSK3-β,
  glycogen synthase kinase 3; LRP5/6, low-density lipoprotein receptor-related protein
  5/6; MEK, mitogen-activated protein kinase kinase; MSX2, homeobox protein MSX-2;
  RUNX2, runt-related transcription factor 2; TCF12, transcription factor 12; ΤGF-β,
  transforming growth factor beta; TGFβR, transforming growth factor beta receptor;
  TCF/LEF, T cell factor/lymphoid enhancer factor; (TWIST), twist-related protein
  1.'
pmcid: PMC5144105
papertitle: 'Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis.'
reftext: Maria A. Katsianou, et al. BBA Clin. 2016 Dec;6:165-176.
pmc_ranked_result_index: '90300'
pathway_score: 0.9581743
filename: gr2.jpg
figtitle: Signal transduction pathways in cranial development
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5144105__gr2.html
  '@type': Dataset
  description: 'Signal transduction pathways in cranial development. The figure schematically
    illustrates the central signal transduction cascades implicated in cranial suture
    development. Possible impairment of these pathways can lead to premature cranial
    fusion thus craniosynostosis. FGF signaling: FGFs (FGF4, FGF3) bind to FGF receptor
    Tyr kinases; FGFRs are phosphorylated hence activated and further activate intracellular
    substrates, which initiate downstream signaling pathways such as the RAS–MAPK
    pathway. The phosphorylated ERK1/2 translocates to the nucleus where it interacts
    with the transcription factor ERF, which is then exported from the nucleus. Within
    the nucleus ERF can bind to RUNX2 and repress RUNX2 expression. TWIST also represses
    RUNX2 by forming a heterodimer with TCF12. Mutations in FGFRs are associated with
    craniosynostosis syndromes, as over-expression of FGFRs triggers the constant
    expression of ERK1/2, thus RUNX2 expression is not abrogated and osteogenesis
    occurs. TGF-β signaling: TGF-β signaling is correlated with downstream ERK1/2.
    BMP signaling: BMPs bind to type I/II transmembrane receptors. Activated receptors
    initiate signaling by phosphorylating downstream targets Smad1, Smad5, Smad8 proteins,
    which interact with Smad4 which translocates into the nucleus. BMP over-expression
    leads to the expression of RUNX2, thus to cranial fusion. BMP signaling is regulated
    by the antagonist Noggin. Wnt signaling: The Wnts signal through the canonical
    β-catenin pathway. Wnts bind to FZD receptors and an accumulation of β-catenin
    is triggered. β-catenin translocates to the nucleus and binds to TCF/LEF transcription
    factors. Subsequent transcription of osteogenic markers follows. BMP, bone morphogenetic
    protein; BMPR, bone morphogenetic protein receptor; CK1, casein kinase 1; DVL,
    the scaffolding protein Disheveled; ERF, ETS domain-containing transcription factor;
    ERK1/2, extracellular signal-regulated kinase 1/2; FGF3 and FGF4, fibroblast growth
    factors 3,4; FGFR1/2/3, fibroblast growth factor receptors 1/2/3; FRAT1 proto-oncogene;
    FZD, Frizzled receptor; GSK3-β, glycogen synthase kinase 3; LRP5/6, low-density
    lipoprotein receptor-related protein 5/6; MEK, mitogen-activated protein kinase
    kinase; MSX2, homeobox protein MSX-2; RUNX2, runt-related transcription factor
    2; TCF12, transcription factor 12; ΤGF-β, transforming growth factor beta; TGFβR,
    transforming growth factor beta receptor; TCF/LEF, T cell factor/lymphoid enhancer
    factor; (TWIST), twist-related protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - HRAS
  - TCF12
  - RAF1
  - ARAF
  - BMP8A
  - MAP2K2
  - BRAF
  - TGFB2
  - LRP6
  - FGFR2
  - MSX2
  - KRAS
  - TGFB3
  - TGFBR1
  - TGFB1
  - FGF3
  - LRP5
  - FGFR1
  - GDF6
  - GDF7
  - GDF1
  - GDF2
  - CTNNB1
  - BMP15
  - TGFBR2
  - NRAS
  - BMP10
  - WNT3A
  - SMAD1
  - FGF4
  - AXIN2
  - SMAD9
  - BMP6
  - BMP7
  - BMP8B
  - GDF5
  - FZD2
  - FZD5
  - TGFBR3
  - TWIST1
  - RUNX2
  - MAPK1
  - SMAD4
  - SMAD5
  - AXIN1
  - BMP4
  - FGFR3
  - FRAT1
  - FZD10
  - WNT3
  - FZD7
  - GDF3
  - DVL1
  - BMP3
  - DVL2
  - MAPK3
  - BMP2
  - FZD3
  - FZD9
  - BMP5
  - BMP1
  - FZD8
  - FZD6
  - DVL3
  - FZD4
  - ERF
  - FZD1
  - Cancer
  - Cardiomyopathy
  - Craniosynostosis
  - Noonan syndrome
genes:
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: TCF12
  symbol: TCF12
  source: hgnc_symbol
  hgnc_symbol: TCF12
  entrez: '6938'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP8A
  entrez: '353500'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: FGFR2
  symbol: FGFR2
  source: hgnc_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: MSX2
  symbol: MSX2
  source: hgnc_symbol
  hgnc_symbol: MSX2
  entrez: '4488'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: FGF3
  symbol: FGF3
  source: hgnc_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: FGFR1
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF6
  entrez: '392255'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF7
  entrez: '151449'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF1
  entrez: '2657'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF2
  entrez: '2658'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP15
  entrez: '9210'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP10
  entrez: '27302'
- word: WNT3A
  symbol: WNT3A
  source: hgnc_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: SMAD1
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: FGF4
  symbol: FGF4
  source: hgnc_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: SMAD8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP6
  entrez: '654'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP7
  entrez: '655'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP8B
  entrez: '656'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF5
  entrez: '8200'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR3
  entrez: '7049'
- word: TWIST1
  symbol: TWIST1
  source: hgnc_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: RUNX2
  symbol: RUNX2
  source: hgnc_symbol
  hgnc_symbol: RUNX2
  entrez: '860'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD5
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP4
  entrez: '652'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FRAT1
  symbol: FRAT1
  source: hgnc_symbol
  hgnc_symbol: FRAT1
  entrez: '10023'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: WNT3.
  symbol: WNT3
  source: hgnc_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF3
  entrez: '9573'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP3
  entrez: '651'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP2
  entrez: '650'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP5
  entrez: '653'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP1
  entrez: '649'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: ERF
  symbol: ERF
  source: hgnc_symbol
  hgnc_symbol: ERF
  entrez: '2077'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Craniosynostosis
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
